Company Overview and News

7
CANADA STOCKS - TSX rises 0.40 percent, best day in a week

31m reuters
NEW YORK, July 19 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 65.61 points, or 0.40 percent, to 16,543.01, its biggest daily percentage gain since July 12. * Leading the index were TransCanada Corp, up 5.4 percent, Guyana Goldfields Inc, up 4.8 percent, and BlackBerry Ltd , higher by 4.3 percent. * Lagging shares were First Quantum Minerals Ltd, down 7.5 percent, Parex Resources Inc, down 5.
ENBBF TRP PXT GUY PARXF ACBFF ENB BBRY GUYFF ENB ACB APH BDRPF FQVLF EBBNF APHQF GYGC FQM

40
Tech Stocks Madness: BlackBerry And Twilio Have The Same Market Cap

2018-07-10 seekingalpha
BlackBerry bears usually compare the formerly Canadian tech giant to the actual tech giants in order to support their bearish narrative.
FB GOOG NVDA BB BBRY TWLO GOOGL AAPL MSFT NOK QCOM BB SNAP

42
BlackBerry's Last Quarter Is Too Bad To Be True

2018-06-28 seekingalpha
BB posted results that were better than expected last week, yet its stock collapsed by more than 20%, due to a guidance not in line with Wall Street’s opinion.
BB BB BBRY

91
BlackBerry-Samsung Sign Deal for Digital Transformation

2018-06-28 zacks
BlackBerry Limited (BB - Free Report) recently inked a multi-year strategic relationship with Samsung Electronics Co. Ltd. to foster the development of integrated solutions and services to accelerate the digital transformation of businesses. The tie-up reinforces the existing business relationship between the two firms dating back to 2014, which brought into the market several enterprise mobility solutions for secure endpoint management and mission-critical communications.
MSI CMTL BC94 SMSN UBNT BB BB BBRY SMSD

92
Telecom Stock Roundup: AT&T's AppNexus Buyout, BlackBerry Q1 Results & More

2018-06-28 zacks
In the last five trading days, telecom stocks declined initially but recovered steeply thereafter, only to partially lose ground later in the week due to the still looming trade war fears with China. The on-again off-again trade war between the United States and China continued to keep the stocks in hot water as both the warring nations vowed to impose tariffs and retaliatory tariffs on each other.
HCTHY GOOG BB BBRY VZA MSI VSAT GOOGL HCLTECH VZ NOKIA 532281 NOK QCOM BB SBAC

79
Tech Stocks Are Killing It in Canada - Bloomberg

2018-06-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SHOP GOOGL MITL GOOG GIB BBRY CNSWF

53
BlackBerry and Samsung Collaborate on Enhanced Digital Transformation Solutions

2018-06-27 globenewswire
WATERLOO, Ontario, June 27, 2018 (GLOBE NEWSWIRE) -- BlackBerry Limited (NYSE:BB) (TSX:BB) today announced a multi-year strategic relationship with Samsung Electronics Co. Ltd. to collaboratively develop and bring to market integrated solutions to accelerate the digital transformation and Enterprise of Things initiatives of their shared business customers.
BC94 DTK SMSN BB BB BBRY SMSD

93
The Banking Revolution Rocking The Finance World

2018-06-25 oilprice
Your license and viewing of our content is subject to the disclosures contained after this article.
OSTK WU FEYE CLS MSFT QPAG BB BBRY

77
BlackBerry to Provide Security Technology to Bullitt Phones

2018-06-25 zacks
BlackBerry Limited (BB - Free Report) recently announced that it has teamed up with Bullitt Group to provide cybersecurity technology to the latter’s select range of connected devices. Bullitt’s Cat and Land Rover branded smartphones will be deemed “BlackBerry Secure” as these will be protected by BlackBerry’s indigenous technology. The joint venture attempts to address the growing demand for high security smartphones and remote monitoring, among both consumer and enterprise customers.
MSI CMTL UBNT BB BB BBRY

77
BlackBerry (BB) Q1 Earnings & Revenues Top on Software Sales

2018-06-25 zacks
BlackBerry Limited (BB - Free Report) reported solid financial results for first-quarter fiscal 2019 (ended May 31, 2018), driven by strong customer demand for its security-focused products, resulting in double-digit year-over-year software and services billing growth. BlackBerry Technology Solutions and the Licensing business reflected the highest momentum. Net Loss On a GAAP basis, net loss for the reported quarter came in at $60 million or a loss of 11 cents per share against net income of $671 million or $1.
MSI CMTL HFC UBNT BB BB BBRY

88
BlackBerry Q1 revenue, adjusted earnings beat estimates but stock falls

2018-06-25 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CATR CAT BBRY

43
BBRY / BlackBerry Ltd. 6-K (Current Report of Foreign Issuer)

2018-06-22 sec.gov
Document UNITED STATES
BBRY

41
BlackBerry Limited (BB) CEO John Chen on Q1 2019 Results - Earnings Call Transcript

2018-06-22 seekingalpha
Good morning and welcome to the BlackBerry Fiscal First Quarter and Fiscal Year 2019 Results Conference Call. My name is Leanne and I will be your conference moderator for today’s call. During the presentation, all participants will be in a listen-only mode. We will be facilitating a brief question-and-answer session towards the end of the conference. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes.
FP BB BB BBRY

40
BlackBerry Ltd. 2018 Q1 - Results - Earnings Call Slides

2018-06-22 seekingalpha
The following slide deck was published by BlackBerry Ltd. in conjunction with their 2018 Q1 earnings call.
BB BB BBRY

89
BlackBerry shares slip on lower enterprise revenue

2018-06-22 cbc.ca
BlackBerry Ltd. shares sank almost 10 per cent to their lowest levels in weeks on Friday, despite beating analysts' estimates and reporting a solid start to its 2019 financial year.
CATR CAT BBRY

BBRY : BlackBerry Ltd Stock Analysis and Research Report

2017-10-26 - Asif

BlackBerry is securing a connected world, delivering innovative solutions across the entire mobile ecosystem and beyond. The Company secures the world’s most sensitive data across all endpoints – from cars to smartphones – making the mobile-first enterprise vision a reality. Founded in 1984 and based in Waterloo, Ontario, the Company operates offices in North America, Europe, Middle East and Africa, Asia Pacific and Latin America. The Company’s common shares are listed on the NASDAQ Global Select Market (“NASDAQ”) (NASDAQ: BBRY) and the Toronto Stock Exchange (“TSX”) (TSX: BB), and its Debentures are listed on the TSX (TSX: BB.DB.U). The Mobile Communications Industry Improvements in wireless network infrastructure and the rapid proliferation of mobile devices and applications in recent years are transforming the way that enterprises and individuals communicate and collaborate. In the enterprise, the mobile platform is becoming the primary computing platform and users now ex...

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 09228F903